Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury

Journal of Clinical Investigation

Volumn 116, Issue 1, 2006, Pages 70-79

  Yanagita, Motoko ^a   Okuda, Tomohiko ^a   Endo, Shuichiro ^a   Tanaka, Mari ^a   Takahashi, Katsu ^a   Sugiyama, Fumihiro ^b   Kunita, Satoshi ^b   Takahashi, Satoru ^b   Fukatsu, Atsushi ^a   Yanagisawa, Masashi ^c,d   Kita, Toru ^a   Sakurai, Takeshi ^b,c  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; PROTEIN INHIBITOR; SMAD PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; GENE; GENE EXPRESSION; KIDNEY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RENAL PROTECTION; SIGNAL TRANSDUCTION; SURVIVAL; UTERINE SENSITIZATION ASSOCIATED GENE 1;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; DNA PRIMERS; FEMALE; GENOMIC LIBRARY; KIDNEY; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS;

EID: 31044453402     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25445     Document Type: Article

References (49)

1. Eddy, A.A. 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7:2495-2508.
2. van Kooten, C., Daha, M.R., and van Es, L.A. 1999. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 7:429-437.
3. Neilson, E.G. 2005. Setting a trap for tissue fibrosis. Nat. Med. 11:373-374.
4. Zeisberg, M., et al. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9:964-968.
5. Vukicevic, S., et al. 1998. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J. Clin. Invest. 102:202-214.
6. Hruska, K.A., et al. 2000. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol. Renal. Physiol. 279:F130-F143.
7. Hruska, K.A. 2002. Treatment of chronic tubulointerstitial disease: a new concept. Kidney Int. 61:1911-1922.
8. Zeisberg, M., et al. 2003. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal. Physiol. 285:F1060-F1067.
9. Dudley, A.T., Lyons, K.M., and Robertson, E.J. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:2795-2807.
10. Luo, G., et al. 1995. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:2808-2820.
11. Ozkaynak, E., et al. 1990. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:2085-2093.
12. Gould, S.E., Day, M., Jones, S.S., and Dorai, H. 2002. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 61:51-60.
13. Simon, M., et al. 1999. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am. J. Physiol. 276:F382-F389.
14. Wang, S.N., Lapage, J., and Hirschberg, R. 2001. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 12:2392-2399.
15. Lund, R.J., Davies, M.R., and Hruska, K.A. 2002. Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr. Opin. Nephrol. Hypertens. 11:31-36.
16. Almanzar, M.M., et al. 1998. Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury. J. Am. Soc. Nephrol. 9:1456-1463.
17. Massague, J., and Chen, Y.G. 2000. Controlling TGF-beta signaling. Genes Dev. 14:627-644.
18. Simmons, D.G., and Kennedy, T.G. 2002. Uterine sensitization-associated gene-1: a novel gene induced within the rat endometrium at the time of uterine receptivity/sensitization for the decidual cell reaction. Biol. Reprod. 67:1638-1645.
19. Avsian-Kretchmer, O., and Hsueh, A.J. 2004. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol. Endocrinol. 18:1-12.
20. Laurikkala, J., Kassai, Y., Pakkasjarvi, L., Thesleff, I., and Itoh, N. 2003. Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev. Biol. 264:91-105.
21. Yanagita, M., et al. 2004. USAG1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem. Biophys. Res. Commun. 316:490-500.
22. Schrier, R.W. 2002. Cancer therapy and renal injury. J. Clin. Invest. 110:743-745. doi:10.1172/JCI200216568.
23. Megyesi, J., Safirstein, R.L., and Price, P.M. 1998. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J. Clin. Invest. 101:777-782.
24. Ramesh, G., and Reeves, W.B. 2002. TNF-á mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110:835-842. doi:10.1172/JCI200215606.
25. Yang, J., and Liu, Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159:1465-1475.
26. Klahr, S., and Morrissey, J. 2002. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal. Physiol. 283:F861-F875.
27. Chevalier, R.L. 1999. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr. Nephrol. 13:612-619.
28. Sato, M., Muragaki, Y., Saika, S., Roberts, A.B., and Ooshima, A. 2003. Targeted disruption of TGFbeta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112:1486-1494. doi:10.1172/JCI200319270.
29. Kalluri, R., and Neilson, E.G. 2003. Epithelialmesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112:1776-1784. doi:10.1172/ JCI200320530.
30. Bottinger, E.P., and Bitzer, M. 2002. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13:2600-2610.
31. Iwano, M., et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350. doi:10.1172/JCI200215518.
32. Zeisberg, M., Shah, A.A., and Kalluri, R. 2005. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280:8094-8100.
33. Gerritsma, J.S., van Kooten, C., Gerritsen, A.F., van Es, L.A., and Daha, M.R. 1998. Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 53:609-616.
34. Li, T., Surendran, K., Zawaideh, M.A., Mathew, S., and Hruska, K.A. 2004. Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr. Opin. Nephrol. Hypertens. 13:417-422.
35. Davies, M.R., Lund, R.J., Mathew, S., and Hruska, K.A. 2005. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J. Am. Soc. Nephrol. 16:917-928.
36. Gonzalez, E.A., et al. 2002. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int. 61:1322-1331.
37. Hruska, K.A., et al. 2004. Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. Semin. Nephrol. 24:25-38.
38. Lund, R.J., Davies, M.R., Brown, A.J., and Hruska, K.A. 2004. Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J. Am. Soc. Nephrol. 15:359-369.
39. Simic, P., and Vukicevic, S. 2005. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev. 16:299-308.
40. Davies, M.R., Lund, R.J., and Hruska, K.A. 2003. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J. Am. Soc. Nephrol. 14:1559-1567.
41. Hruska, K.A., Mathew, S., and Saab, G. 2005. Bone morphogenetic proteins in vascular calcification. Circ. Res. 97:105-114.
42. Godin, R.E., Takaesu, N.T., Robertson, E.J., and Dudley, A.T. 1998. Regulation of BMP7 expression during kidney development. Development. 125:3473-3482.
43. Michos, O., et al. 2004. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development. 131:3401-3410.
44. Itasaki, N., et al. 2003. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development. 130:4295-4305.
45. Lin, J., et al. 2005. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat. Med. 11:387-393.
46. Nishida, M., et al. 2002. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J. Clin. Invest. 110:1859-1868. doi:10.1172/JCI200215045.
47. Yanagita, M., et al. 2001. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol. 158:1423-1432.
48. Yanagita, M., et al. 2001. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J. Biol. Chem. 276:42364-42369.
49. Yanagita, M., et al. 2002. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Invest. 110:239-246. doi:10.1172/ JCI200214861.